All In Biotech

Drug Trial Radar · NCT01960075

Established Status Epilepticus Treatment Trial

A Multicenter, Randomized, Blinded, Comparative Effectiveness Study of Fosphenytoin, Valproic Acid, or Levetiracetam in the Emergency Department Treatment of Patients With Benzodiazepine-refractory Status Epilepticus.

Last checked: Nov 20, 2026Latest source record: Jun 14, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 478 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

478

Actual

Start

Oct 2015

Primary completion

Feb 2019

Study completion May 2019

Sponsor

Lead sponsor
University of VirginiaAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
University of Michigan; Medical University of South Carolina; Children's National Research Institute; University of Minnesota; National Institute of Neurological Disorders and Stroke (NINDS)
First posted
Oct 10, 2013

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 2 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective is to determine the most effective and/or the least effective treatment of benzodiazepine-refractory status epilepticus (SE) among patients older than 2 years. There are three active treatment arms being compared: fosphenytoin (FOS),levetiracetam (LEV), and valproic acid (VPA). The second objective is comparison of three drugs with respect to secondary outcomes. The final objective is to ensure that the trial is informative for treatment of established SE in children by describing the effectiveness, safety, and rate of adverse reactions of these drugs in children.

Conditions

  • Benzodiazepine Refractory Status Epilepticus

Interventions

  • FosphenytoinDrug

  • LevetiracetamDrug

  • Valproic acidDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Clinical Cessation of Status Epilepticus - Intention to TreatTime frame: Within 60 minutes after the start of study drug infusion
  2. Number of Participants With Clinical Cessation of Status Epilepticus - Per-protocol AnalysisTime frame: Within 60 minutes after the start of study drug infusion
  3. Number of Participants With Clinical Cessation of Status Epilepticus - Adjudicated Outcomes AnalysisTime frame: Within 60 minutes after the start of study drug infusion

Locations

65 sites in 1 country. Site status is shown where the registry gives one.

  • Banner University Medical Center - South Campus

    Tucson, Arizona

  • Banner University Medical Center-Tucson Campus

    Tucson, Arizona

  • Ronald Reagan UCLA Medical Center

    Los Angeles, California

  • UC Davis Children's Hospital

    Sacramento, California

  • San Francisco General Hospital

    San Francisco, California

  • UCSF Medical Center

    San Francisco, California

  • UCSF Benioff Children's Hospital

    San Francisco, California

  • Stanford University Medical Center

    Stanford, California

  • Christiana Hospital

    Newark, Delaware

  • A.I.DuPont Hospital for Children

    Wilmington, Delaware

  • Children's National Medical Center

    Washington D.C., District of Columbia

  • Grady Memorial Hospital

    Atlanta, Georgia

  • Children's Healthcare of Atlanta at Egleston

    Atlanta, Georgia

  • University of Kentucky Hospital

    Lexington, Kentucky

  • University of maryland Medical Center

    Baltimore, Maryland

  • Massachusetts General Hospital

    Boston, Massachusetts

  • C.S. Mott Children's Hospital

    Ann Arbor, Michigan

  • University of Michigan Medical Center

    Ann Arbor, Michigan

  • Children's Hospital of Michigan

    Detroit, Michigan

  • Detroit Receiving Hospital

    Detroit, Michigan

  • Henry Ford Hospital

    Detroit, Michigan

  • Sinai-Grace Hospital

    Detroit, Michigan

  • Fairview Southdale Hospital

    Edina, Minnesota

  • Hennepin County Medical Center

    Minneapolis, Minnesota

  • University of Minnesota Medical Center

    Minneapolis, Minnesota

  • University of Minnesota Masonic Children's Hospital

    Minneapolis, Minnesota

  • Regions Hospital

    Saint Paul, Minnesota

  • St. Louis Children's Hospital

    St Louis, Missouri

  • Hackensack University Medical Center

    Hackensack, New Jersey

  • Kings County Hospital Center

    Brooklyn, New York

  • SUNY Downstate Medical Center

    Brooklyn, New York

  • Maimonides Medical Center

    Brooklyn, New York

  • NYP Columbia University Medical Center

    New York, New York

  • NYP Morgan Stanley Children's Hospital

    New York, New York

  • University of Cincinnati Medical Center

    Cincinnati, Ohio

  • Cincinnati Children's Hospital Medical Center

    Cincinnati, Ohio

  • Nationwide Children's Hospital

    Columbus, Ohio

  • OSU Wexner Medical Center

    Columbus, Ohio

  • Oregon Health & Science University Hospital

    Portland, Oregon

  • Crozer-Chester Medical Center

    Chester, Pennsylvania

Showing 40 of 65 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.